Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daichi Sadato

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
DEN Open|June 8, 2026
Worst Histology-Based Risk Stratification for Lymph Node Metastasis in Patients With T1b Colorectal Cancer: A Retrospective Pathology-based StudySatomi Shibata, Shin-Ichiro Horiguchi, Koichi Koizumi, et al.
Leukemia & Lymphoma|September 14, 2022
Labile CD22 and CD19 expression in a case of Philadelphia chromosome-like acute lymphoblastic leukemiaJunichi Mukae, Daichi Sadato, Takashi Toya, et al.
Scientific Reports|February 14, 2023
Impact of gene alterations on clinical outcome in young adults with myelodysplastic syndromesTatsuya Konishi, Daichi Sadato, Takashi Toya, et al.
British Journal of Haematology|July 27, 2021
Donor-derived gene mutations in sex chromosome loss after stem cell transplantationHiroto Adachi, Daichi Sadato, Takashi Toya, et al.
Cancer Science|September 26, 2022
Attenuated humoral response against SARS-CoV-2 mRNA vaccination in allogeneic stem cell transplantation recipientsTakashi Toya, Yuya Atsuta, Takahiro Sanada, et al.
Bone Marrow Transplantation|August 8, 2020
Prognostic impact of TP53 mutation, monosomal karyotype, and prior myeloid disorder in nonremission acute myeloid leukemia at allo-HSCTYuho Najima, Daichi Sadato, Yuka Harada, et al.
Acta Haematologica|June 1, 2021
Successful Cord Blood Transplantation for Idiopathic CD4+ LymphocytopeniaKeita Yamamoto, Yuho Najima, Hiroko Iizuka, et al.
Bone Marrow Transplantation|May 23, 2024
Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignanciesSatoshi Kaito, Yuho Najima, Daichi Sadato, et al.
Hematology (Amsterdam, Netherlands)|July 29, 2025
Ponatinib/blinatumomab for relapsed Philadelphia chromosome-positive leukemia as a bridge to allogeneic transplantationYasutaka Sadaga, Daisuke Watanabe, Yuho Najima, et al.
Frontiers in Immunology|February 13, 2025
Changes in donor lymphocyte infusion for relapsed patients post-hematopoietic stem cell transplantation: a 30-year single-center experienceYusuke Uchibori, Shuhei Kurosawa, Yuho Najima, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
DEN Open|June 8, 2026
Worst Histology-Based Risk Stratification for Lymph Node Metastasis in Patients With T1b Colorectal Cancer: A Retrospective Pathology-based StudySatomi Shibata, Shin-Ichiro Horiguchi, Koichi Koizumi, et al.
Leukemia & Lymphoma|September 14, 2022
Labile CD22 and CD19 expression in a case of Philadelphia chromosome-like acute lymphoblastic leukemiaJunichi Mukae, Daichi Sadato, Takashi Toya, et al.
Scientific Reports|February 14, 2023
Impact of gene alterations on clinical outcome in young adults with myelodysplastic syndromesTatsuya Konishi, Daichi Sadato, Takashi Toya, et al.
British Journal of Haematology|July 27, 2021
Donor-derived gene mutations in sex chromosome loss after stem cell transplantationHiroto Adachi, Daichi Sadato, Takashi Toya, et al.
Cancer Science|September 26, 2022
Attenuated humoral response against SARS-CoV-2 mRNA vaccination in allogeneic stem cell transplantation recipientsTakashi Toya, Yuya Atsuta, Takahiro Sanada, et al.
Bone Marrow Transplantation|August 8, 2020
Prognostic impact of TP53 mutation, monosomal karyotype, and prior myeloid disorder in nonremission acute myeloid leukemia at allo-HSCTYuho Najima, Daichi Sadato, Yuka Harada, et al.
Acta Haematologica|June 1, 2021
Successful Cord Blood Transplantation for Idiopathic CD4+ LymphocytopeniaKeita Yamamoto, Yuho Najima, Hiroko Iizuka, et al.
Bone Marrow Transplantation|May 23, 2024
Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignanciesSatoshi Kaito, Yuho Najima, Daichi Sadato, et al.
Hematology (Amsterdam, Netherlands)|July 29, 2025
Ponatinib/blinatumomab for relapsed Philadelphia chromosome-positive leukemia as a bridge to allogeneic transplantationYasutaka Sadaga, Daisuke Watanabe, Yuho Najima, et al.
Frontiers in Immunology|February 13, 2025
Changes in donor lymphocyte infusion for relapsed patients post-hematopoietic stem cell transplantation: a 30-year single-center experienceYusuke Uchibori, Shuhei Kurosawa, Yuho Najima, et al.
Pageof 5